US Food and Drug Administration Clears Expanded Access Pathway for Daraxonrasib
Regulator issues “safe to proceed” letter to Revolution Medicines, enabling early patient access to investigational therapy for advanced pancreatic cancer.
Investigational Drug | 04/05/2026 | By News Bureau | 136
Vascarta's Curcumin Gel Shows Promising Results in Reducing Osteoarthritis Knee Pain
Clinical trial findings reveal significant pain reduction and strong safety profile for investigational topical gel VAS-101 in adults with knee osteoarthritis.
Investigational Drug | 02/04/2026 | By News Bureau | 490
Pharming Completes Enrollment in Pediatric Clinical Trial of leniolisib
Pharming Group has recently completed patient enrollment in its Phase III clinical trial (NCT05438407) evaluating the investigational drug leniolisib.
Investigational Drug | 09/04/2024 | By Aishwarya | 514
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy